On-body Injectors Market Research Report from 2023 forecast to 2029, by Manufacturers, Regions, Type and Application

The global On-body Injectors market size was valued at USD 148.2 million in 2022 and is forecast to a readjusted size of USD 378.9 million by 2029 with a CAGR of 14.4% during review period.

On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.

In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorized on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.

Report includes an overview of the development of the On-body Injectors industry chain, the market status of Immuno-oncology (Electronic Injectors, Mechanical Injectors), cardiovascular diseases (Electronic Injectors, Mechanical Injectors), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of On-body Injectors.

Regionally, the report analyzes the On-body Injectors markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global On-body Injectors market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:

The report presents comprehensive understanding of the On-body Injectors market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the On-body Injectors industry.

The report involves analyzing the market at a macro level:

Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Electronic Injectors, Mechanical Injectors).

Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the On-body Injectors market.

Regional Analysis: The report involves examining the On-body Injectors market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the On-body Injectors market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to On-body Injectors:

Company Analysis: Report covers individual On-body Injectors manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards On-body Injectors This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immuno-oncology, cardiovascular diseases).

Technology Analysis: Report covers specific technologies relevant to On-body Injectors. It assesses the current state, advancements, and potential future developments in On-body Injectors areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the On-body Injectors market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

   West Pharmaceutical Services
   Insulet
   Gerresheimer
   United Therapeutics
   CC Bio
   BD
   Ypsomed
   Enable Injections
   Nemera
   Stevanato Group
   Sonceboz
   Lohmann Therapie-Systeme
   Elcam Drug Delivery Devices (E3D)

   Electronic Injectors
   Mechanical Injectors

   Immuno-oncology
   Cardiovascular Diseases
   Neurological Diseases
   Others

   North America (United States, Canada and Mexico)
   Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
   Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
   South America (Brazil, Argentina, Colombia, and Rest of South America)
   Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

What are the strengths of the On-body Injectors Market in 2025?

On-body injectors offer significant convenience for patients, reducing the need for hospital visits and enabling self-administration of medications. Their advanced design increases patient compliance, improves medication accuracy, and allows for more frequent treatment schedules. Additionally, they are highly beneficial in chronic conditions like diabetes and autoimmune diseases, where long-term medication is required.

What are the weaknesses of the On-body Injectors Market in 2025?

The high initial cost of on-body injectors may be a barrier for widespread adoption, especially in emerging markets. Technical challenges such as potential device malfunction or improper usage can also pose risks to patients. Additionally, there may be concerns regarding the comfort and skin irritation associated with wearing the device for extended periods.

What are the opportunities in the On-body Injectors Market in 2025?

There is growing demand for personalized medicine and remote patient monitoring, which opens up opportunities for on-body injectors to integrate with digital health platforms. Technological advancements could improve ease of use, reduce costs, and expand the product range to include treatments for a wider variety of conditions. The market can also benefit from expanding into underserved regions with high prevalence of chronic diseases.

What are the threats to the On-body Injectors Market in 2025?

The emergence of alternative drug delivery systems, such as oral biologics or sublingual tablets, could potentially limit the growth of on-body injectors. Regulatory hurdles and the complexity of medical device approval processes may slow down innovation and market penetration. Additionally, competition from established injectable drug delivery methods and concerns about data privacy in connected devices could hinder market expansion.

What are the political factors affecting the On-body Injectors Market in 2025?

Government regulations and healthcare policies play a significant role in the development and adoption of on-body injectors. Policies that encourage innovation in medical devices, as well as government reimbursement for chronic disease treatments, will positively influence the market. However, political instability or regulatory changes in key regions could delay product approval and market entry.

How do economic factors impact the On-body Injectors Market in 2025?

The cost of on-body injectors may limit accessibility, particularly in lower-income markets. Economic downturns or reduced healthcare spending could impact the growth of the market. However, as healthcare systems increasingly shift toward cost-effective outpatient care, the long-term savings from reducing hospital visits may encourage investment in on-body injectors.

What are the social factors influencing the On-body Injectors Market in 2025?

Growing awareness and acceptance of self-administered treatments, particularly in chronic disease management, are boosting the demand for on-body injectors. Social trends focusing on personalized care and patient autonomy will continue to shape market growth. Additionally, the aging population and rise in chronic conditions will increase the demand for such devices.

How does technology affect the On-body Injectors Market in 2025?

Advancements in miniaturization, sensor integration, and connectivity are driving innovation in on-body injectors. New technologies can improve user experience, enhance precision in drug delivery, and enable remote monitoring of patient data. However, there are concerns regarding cybersecurity risks and data privacy issues related to connected devices.

What are the environmental factors influencing the On-body Injectors Market in 2025?

There is increasing pressure on the healthcare industry to adopt environmentally sustainable practices. The need for eco-friendly packaging and disposal methods for single-use devices will grow. Manufacturers may also face challenges in developing sustainable production methods that minimize environmental impact while maintaining product efficiency.

What are the legal factors affecting the On-body Injectors Market in 2025?

Strict regulatory standards governing medical devices, such as FDA approval and CE marking, will continue to shape the market. Manufacturers must comply with laws related to product safety, efficacy, and intellectual property. Legal challenges related to patents, device recalls, and liability issues could impact the growth of the market.

Who are the suppliers in the On-body Injectors Market in 2025?

Suppliers include manufacturers of medical device components such as sensors, injectors, and cartridges. Suppliers of raw materials for the device's structure and packaging also play a critical role. Additionally, technology providers that offer software for connectivity and data integration are key suppliers.

What are the inputs for the On-body Injectors Market in 2025?

Inputs include raw materials like plastics and metals for the device structure, pharmaceutical drugs for injection, and technological innovations in microelectronics, sensors, and connectivity. Research and development efforts focused on improving device performance and usability also contribute as vital inputs.

What are the processes involved in the On-body Injectors Market in 2025?

Processes include design and development of the injector device, testing for safety and efficacy, regulatory approval processes, production and assembly of devices, and distribution. Additionally, customer support, training for users, and post-market surveillance are key processes to ensure proper use and monitor the product's performance.

Who are the customers in the On-body Injectors Market in 2025?

Customers primarily include patients who require chronic disease management, healthcare providers, and hospitals. Pharmaceutical companies offering injectable treatments are also important customers, as they often partner with device manufacturers for co-marketing or integration with their drugs.

What are the outputs in the On-body Injectors Market in 2025?

Outputs include the finished on-body injectors, which are ready for patient use. Additionally, connected devices that provide real-time monitoring, data analytics for healthcare professionals, and post-use data reports for improving patient outcomes are key outputs of the market.

What is the threat of new entrants in the On-body Injectors Market in 2025?

The threat of new entrants is moderate. While technological advancements make it easier for new companies to enter the market, the high regulatory barriers, significant capital investment, and the need for specialized expertise in medical devices limit the number of new competitors. Established players with a strong market presence have an advantage.

What is the bargaining power of suppliers in the On-body Injectors Market in 2025?

The bargaining power of suppliers is moderate. Key suppliers provide critical components such as sensors, microelectronics, and drug delivery mechanisms. While there are several suppliers for these components, high-quality and reliable suppliers are limited, which gives them moderate power in influencing prices and terms.

What is the bargaining power of buyers in the On-body Injectors Market in 2025?

The bargaining power of buyers is relatively low. On-body injectors are specialized devices, and the demand from patients with chronic conditions and healthcare providers is consistent. While some competition exists, there is limited direct influence from individual buyers, as healthcare systems and insurance companies typically determine pricing and accessibility.

What is the threat of substitute products in the On-body Injectors Market in 2025?

The threat of substitutes is moderate. While alternative drug delivery methods such as traditional injections or oral medications exist, on-body injectors provide a level of convenience and precision that is not easily replicated. However, emerging technologies like wearable drug delivery patches and oral biologics may pose a future challenge.

What is the intensity of competitive rivalry in the On-body Injectors Market in 2025?

The intensity of competitive rivalry is high. The market is becoming more crowded as existing medical device manufacturers and pharmaceutical companies continue to innovate and expand their portfolios. Competition is driven by the need for differentiation in device design, ease of use, pricing, and integration with digital health technologies.

What are the key suppliers in the On-body Injectors Market in 2025?

Key suppliers include manufacturers of materials like plastics, metals, and microelectronics for the device construction. Suppliers of pharmaceutical-grade drugs used in the injectors are also crucial, as are companies providing sensor technology and software for device connectivity and monitoring.

What raw materials are critical in the production of On-body Injectors?

Critical raw materials include biocompatible plastics and polymers for the outer casing, metals for structural integrity, and silicon or microelectronics for the internal components. High-quality drug delivery components, including pre-filled syringes and drug cartridges, are essential to ensure the effectiveness of the injectors.

How does technology impact the upstream processes for On-body Injectors?

Technology is a major driver in upstream processes, particularly in sensor integration, miniaturization, and connectivity. Advances in microelectronics and wireless communication are vital for improving injector performance. R&D efforts to improve device usability and patient comfort are essential upstream activities that shape product design.

What are the challenges in the upstream supply chain for On-body Injectors?

Challenges include the high cost and complexity of sourcing specialized components, particularly sensors, and microelectronics. The need for regulatory compliance across multiple regions can also complicate the supply chain. Additionally, global supply chain disruptions, such as shortages in raw materials or transportation delays, could impact production timelines.

How does regulatory approval affect upstream operations for On-body Injectors?

Regulatory approval is a key consideration for upstream operations. Manufacturers must ensure all raw materials and components meet stringent safety and quality standards. Delays in obtaining regulatory approval for new materials or technologies can hinder the production process and increase costs. Compliance with medical device regulations is critical for avoiding potential disruptions.

What are the key processes in the midstream segment of the On-body Injectors Market in 2025?

Key processes in the midstream segment include device assembly, quality control, and packaging. After manufacturing, on-body injectors undergo rigorous testing to ensure they meet safety and performance standards. The integration of sensors and connectivity features also takes place during this phase, as well as the sterilization and packaging of the devices for distribution.

How does manufacturing scale impact the On-body Injectors Market?

The scale of manufacturing directly impacts production costs and device availability. As demand increases, manufacturers must scale up production while maintaining high-quality standards and compliance with regulations. Large-scale production can also help reduce costs, making on-body injectors more affordable and accessible to a larger patient population.

What role does distribution play in the midstream process for On-body Injectors?

Distribution plays a critical role in ensuring on-body injectors reach healthcare providers, pharmacies, and patients in a timely manner. Efficient logistics networks are required for global and regional delivery, while ensuring that the injectors remain in proper conditions during transportation. Distribution partners, such as wholesalers and healthcare institutions, also contribute to the market’s reach and growth.

What challenges are faced in the midstream phase of the On-body Injectors Market?

Challenges in the midstream phase include maintaining consistency in product quality, dealing with production delays, and ensuring compliance with regulations across different regions. Additionally, integrating new technologies like sensors and connectivity may introduce complexities in the manufacturing process. There is also the risk of supply chain disruptions, affecting the timely delivery of components and final products.

How does technology integration impact midstream operations for On-body Injectors?

Technology integration is crucial in the midstream phase, especially for the incorporation of digital connectivity and real-time monitoring systems in on-body injectors. The use of smart sensors, data analytics, and patient tracking features enhances the injector’s capabilities but also adds complexity to manufacturing and assembly processes. This integration requires skilled labor and specialized equipment, impacting both cost and production timelines.

What are the key activities in the downstream segment of the On-body Injectors Market in 2025?

Key activities in the downstream segment include the distribution and sale of on-body injectors to healthcare providers, pharmacies, and directly to patients. After the injectors reach the market, training for healthcare professionals and patients on proper usage, as well as ongoing customer support, are essential activities to ensure proper adoption and usage.

How does market demand influence the downstream processes for On-body Injectors?

Market demand drives the volume of injectors produced and distributed. Higher demand for chronic disease management solutions leads to increased distribution efforts, partnerships with healthcare providers, and marketing strategies aimed at educating patients. Demand fluctuations also affect pricing, availability, and the prioritization of certain therapies or treatments.

What role do healthcare providers and pharmacies play in the downstream process?

Healthcare providers and pharmacies act as critical intermediaries between the manufacturer and the patient. They ensure that on-body injectors are prescribed correctly, train patients on how to use them, and offer support throughout the treatment process. They also play a key role in ensuring the devices are integrated into existing treatment protocols for various conditions.

What challenges are faced in the downstream phase of the On-body Injectors Market?

Challenges include ensuring the availability of on-body injectors in all regions, especially in underserved areas, and addressing the reluctance of patients or healthcare providers to adopt new technology. There are also challenges related to patient education, reimbursement issues, and integration with existing healthcare systems. Additionally, any issues with product performance or recalls can affect market trust.

How does patient education impact the downstream processes for On-body Injectors?

Patient education is crucial for the successful adoption of on-body injectors. Proper training on device usage, safety protocols, and troubleshooting is necessary to reduce the risk of misuse and ensure effective treatment. Educational programs can also alleviate concerns regarding the new technology, improving patient compliance and overall satisfaction with the treatment.

Chapter 1, to describe On-body Injectors product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of On-body Injectors, with price, sales, revenue and global market share of On-body Injectors from 2018 to 2023.
Chapter 3, the On-body Injectors competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the On-body Injectors breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and On-body Injectors market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of On-body Injectors.
Chapter 14 and 15, to describe On-body Injectors sales channel, distributors, customers, research findings and conclusion.

1 Market Overview

   1.1 Product Overview and Scope of On-body Injectors
   1.2 Market Estimation Caveats and Base Year
   1.3 Market Analysis by Type
       1.3.1 Overview: Global On-body Injectors Consumption Value by Type: 2018 Versus 2022 Versus 2029
       1.3.2 Electronic Injectors
       1.3.3 Mechanical Injectors
   1.4 Market Analysis by Application
       1.4.1 Overview: Global On-body Injectors Consumption Value by Application: 2018 Versus 2022 Versus 2029
       1.4.2 Immuno-oncology
       1.4.3 Cardiovascular Diseases
       1.4.4 Neurological Diseases
       1.4.5 Others
   1.5 Global On-body Injectors Market Size & Forecast
       1.5.1 Global On-body Injectors Consumption Value (2018 & 2022 & 2029)
       1.5.2 Global On-body Injectors Sales Quantity (2018-2029)
       1.5.3 Global On-body Injectors Average Price (2018-2029)

2 Manufacturers Profiles

   2.1 West Pharmaceutical Services
       2.1.1 West Pharmaceutical Services Details
       2.1.2 West Pharmaceutical Services Major Business
       2.1.3 West Pharmaceutical Services On-body Injectors Product and Services
       2.1.4 West Pharmaceutical Services On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.1.5 West Pharmaceutical Services Recent Developments/Updates
   2.2 Insulet
       2.2.1 Insulet Details
       2.2.2 Insulet Major Business
       2.2.3 Insulet On-body Injectors Product and Services
       2.2.4 Insulet On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.2.5 Insulet Recent Developments/Updates
   2.3 Gerresheimer
       2.3.1 Gerresheimer Details
       2.3.2 Gerresheimer Major Business
       2.3.3 Gerresheimer On-body Injectors Product and Services
       2.3.4 Gerresheimer On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.3.5 Gerresheimer Recent Developments/Updates
   2.4 United Therapeutics
       2.4.1 United Therapeutics Details
       2.4.2 United Therapeutics Major Business
       2.4.3 United Therapeutics On-body Injectors Product and Services
       2.4.4 United Therapeutics On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.4.5 United Therapeutics Recent Developments/Updates
   2.5 CC Bio
       2.5.1 CC Bio Details
       2.5.2 CC Bio Major Business
       2.5.3 CC Bio On-body Injectors Product and Services
       2.5.4 CC Bio On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.5.5 CC Bio Recent Developments/Updates
   2.6 BD
       2.6.1 BD Details
       2.6.2 BD Major Business
       2.6.3 BD On-body Injectors Product and Services
       2.6.4 BD On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.6.5 BD Recent Developments/Updates
   2.7 Ypsomed
       2.7.1 Ypsomed Details
       2.7.2 Ypsomed Major Business
       2.7.3 Ypsomed On-body Injectors Product and Services
       2.7.4 Ypsomed On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.7.5 Ypsomed Recent Developments/Updates
   2.8 Enable Injections
       2.8.1 Enable Injections Details
       2.8.2 Enable Injections Major Business
       2.8.3 Enable Injections On-body Injectors Product and Services
       2.8.4 Enable Injections On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.8.5 Enable Injections Recent Developments/Updates
   2.9 Nemera
       2.9.1 Nemera Details
       2.9.2 Nemera Major Business
       2.9.3 Nemera On-body Injectors Product and Services
       2.9.4 Nemera On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.9.5 Nemera Recent Developments/Updates
   2.10 Stevanato Group
       2.10.1 Stevanato Group Details
       2.10.2 Stevanato Group Major Business
       2.10.3 Stevanato Group On-body Injectors Product and Services
       2.10.4 Stevanato Group On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.10.5 Stevanato Group Recent Developments/Updates
   2.11 Sonceboz
       2.11.1 Sonceboz Details
       2.11.2 Sonceboz Major Business
       2.11.3 Sonceboz On-body Injectors Product and Services
       2.11.4 Sonceboz On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.11.5 Sonceboz Recent Developments/Updates
   2.12 Lohmann Therapie-Systeme
       2.12.1 Lohmann Therapie-Systeme Details
       2.12.2 Lohmann Therapie-Systeme Major Business
       2.12.3 Lohmann Therapie-Systeme On-body Injectors Product and Services
       2.12.4 Lohmann Therapie-Systeme On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
   2.13 Elcam Drug Delivery Devices (E3D)
       2.13.1 Elcam Drug Delivery Devices (E3D) Details
       2.13.2 Elcam Drug Delivery Devices (E3D) Major Business
       2.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
       2.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
       2.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates

3 Competitive Environment: On-body Injectors by Manufacturer

   3.1 Global On-body Injectors Sales Quantity by Manufacturer (2018-2023)
   3.2 Global On-body Injectors Revenue by Manufacturer (2018-2023)
   3.3 Global On-body Injectors Average Price by Manufacturer (2018-2023)
   3.4 Market Share Analysis (2022)
       3.4.1 Producer Shipments of On-body Injectors by Manufacturer Revenue ($MM) and Market Share (%): 2022
       3.4.2 Top 3 On-body Injectors Manufacturer Market Share in 2022
       3.4.2 Top 6 On-body Injectors Manufacturer Market Share in 2022
   3.5 On-body Injectors Market: Overall Company Footprint Analysis
       3.5.1 On-body Injectors Market: Region Footprint
       3.5.2 On-body Injectors Market: Company Product Type Footprint
       3.5.3 On-body Injectors Market: Company Product Application Footprint
   3.6 New Market Entrants and Barriers to Market Entry
   3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

   4.1 Global On-body Injectors Market Size by Region
       4.1.1 Global On-body Injectors Sales Quantity by Region (2018-2029)
       4.1.2 Global On-body Injectors Consumption Value by Region (2018-2029)
       4.1.3 Global On-body Injectors Average Price by Region (2018-2029)
   4.2 North America On-body Injectors Consumption Value (2018-2029)
   4.3 Europe On-body Injectors Consumption Value (2018-2029)
   4.4 Asia-Pacific On-body Injectors Consumption Value (2018-2029)
   4.5 South America On-body Injectors Consumption Value (2018-2029)
   4.6 Middle East and Africa On-body Injectors Consumption Value (2018-2029)

5 Market Segment by Type

   5.1 Global On-body Injectors Sales Quantity by Type (2018-2029)
   5.2 Global On-body Injectors Consumption Value by Type (2018-2029)
   5.3 Global On-body Injectors Average Price by Type (2018-2029)

6 Market Segment by Application

   6.1 Global On-body Injectors Sales Quantity by Application (2018-2029)
   6.2 Global On-body Injectors Consumption Value by Application (2018-2029)
   6.3 Global On-body Injectors Average Price by Application (2018-2029)

7 North America

   7.1 North America On-body Injectors Sales Quantity by Type (2018-2029)
   7.2 North America On-body Injectors Sales Quantity by Application (2018-2029)
   7.3 North America On-body Injectors Market Size by Country
       7.3.1 North America On-body Injectors Sales Quantity by Country (2018-2029)
       7.3.2 North America On-body Injectors Consumption Value by Country (2018-2029)
       7.3.3 United States Market Size and Forecast (2018-2029)
       7.3.4 Canada Market Size and Forecast (2018-2029)
       7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

   8.1 Europe On-body Injectors Sales Quantity by Type (2018-2029)
   8.2 Europe On-body Injectors Sales Quantity by Application (2018-2029)
   8.3 Europe On-body Injectors Market Size by Country
       8.3.1 Europe On-body Injectors Sales Quantity by Country (2018-2029)
       8.3.2 Europe On-body Injectors Consumption Value by Country (2018-2029)
       8.3.3 Germany Market Size and Forecast (2018-2029)
       8.3.4 France Market Size and Forecast (2018-2029)
       8.3.5 United Kingdom Market Size and Forecast (2018-2029)
       8.3.6 Russia Market Size and Forecast (2018-2029)
       8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

   9.1 Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2029)
   9.2 Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2029)
   9.3 Asia-Pacific On-body Injectors Market Size by Region
       9.3.1 Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2029)
       9.3.2 Asia-Pacific On-body Injectors Consumption Value by Region (2018-2029)
       9.3.3 China Market Size and Forecast (2018-2029)
       9.3.4 Japan Market Size and Forecast (2018-2029)
       9.3.5 Korea Market Size and Forecast (2018-2029)
       9.3.6 India Market Size and Forecast (2018-2029)
       9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
       9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

   10.1 South America On-body Injectors Sales Quantity by Type (2018-2029)
   10.2 South America On-body Injectors Sales Quantity by Application (2018-2029)
   10.3 South America On-body Injectors Market Size by Country
       10.3.1 South America On-body Injectors Sales Quantity by Country (2018-2029)
       10.3.2 South America On-body Injectors Consumption Value by Country (2018-2029)
       10.3.3 Brazil Market Size and Forecast (2018-2029)
       10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

   11.1 Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2029)
   11.2 Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2029)
   11.3 Middle East & Africa On-body Injectors Market Size by Country
       11.3.1 Middle East & Africa On-body Injectors Sales Quantity by Country (2018-2029)
       11.3.2 Middle East & Africa On-body Injectors Consumption Value by Country (2018-2029)
       11.3.3 Turkey Market Size and Forecast (2018-2029)
       11.3.4 Egypt Market Size and Forecast (2018-2029)
       11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
       11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

   12.1 On-body Injectors Market Drivers
   12.2 On-body Injectors Market Restraints
   12.3 On-body Injectors Trends Analysis
   12.4 Porters Five Forces Analysis
       12.4.1 Threat of New Entrants
       12.4.2 Bargaining Power of Suppliers
       12.4.3 Bargaining Power of Buyers
       12.4.4 Threat of Substitutes
       12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

   13.1 Raw Material of On-body Injectors and Key Manufacturers
   13.2 Manufacturing Costs Percentage of On-body Injectors
   13.3 On-body Injectors Production Process
   13.4 On-body Injectors Industrial Chain

14 Shipments by Distribution Channel

   14.1 Sales Channel
       14.1.1 Direct to End-User
       14.1.2 Distributors
   14.2 On-body Injectors Typical Distributors
   14.3 On-body Injectors Typical Customers

15 Research Findings and Conclusion

16 Appendix

   16.1 Methodology
   16.2 Research Process and Data Source
   16.3 Disclaimer

List of Tables

   Table 1. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Table 2. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Table 3. West Pharmaceutical Services Basic Information, Manufacturing Base and Competitors
   Table 4. West Pharmaceutical Services Major Business
   Table 5. West Pharmaceutical Services On-body Injectors Product and Services
   Table 6. West Pharmaceutical Services On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 7. West Pharmaceutical Services Recent Developments/Updates
   Table 8. Insulet Basic Information, Manufacturing Base and Competitors
   Table 9. Insulet Major Business
   Table 10. Insulet On-body Injectors Product and Services
   Table 11. Insulet On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 12. Insulet Recent Developments/Updates
   Table 13. Gerresheimer Basic Information, Manufacturing Base and Competitors
   Table 14. Gerresheimer Major Business
   Table 15. Gerresheimer On-body Injectors Product and Services
   Table 16. Gerresheimer On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 17. Gerresheimer Recent Developments/Updates
   Table 18. United Therapeutics Basic Information, Manufacturing Base and Competitors
   Table 19. United Therapeutics Major Business
   Table 20. United Therapeutics On-body Injectors Product and Services
   Table 21. United Therapeutics On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 22. United Therapeutics Recent Developments/Updates
   Table 23. CC Bio Basic Information, Manufacturing Base and Competitors
   Table 24. CC Bio Major Business
   Table 25. CC Bio On-body Injectors Product and Services
   Table 26. CC Bio On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 27. CC Bio Recent Developments/Updates
   Table 28. BD Basic Information, Manufacturing Base and Competitors
   Table 29. BD Major Business
   Table 30. BD On-body Injectors Product and Services
   Table 31. BD On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 32. BD Recent Developments/Updates
   Table 33. Ypsomed Basic Information, Manufacturing Base and Competitors
   Table 34. Ypsomed Major Business
   Table 35. Ypsomed On-body Injectors Product and Services
   Table 36. Ypsomed On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 37. Ypsomed Recent Developments/Updates
   Table 38. Enable Injections Basic Information, Manufacturing Base and Competitors
   Table 39. Enable Injections Major Business
   Table 40. Enable Injections On-body Injectors Product and Services
   Table 41. Enable Injections On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 42. Enable Injections Recent Developments/Updates
   Table 43. Nemera Basic Information, Manufacturing Base and Competitors
   Table 44. Nemera Major Business
   Table 45. Nemera On-body Injectors Product and Services
   Table 46. Nemera On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 47. Nemera Recent Developments/Updates
   Table 48. Stevanato Group Basic Information, Manufacturing Base and Competitors
   Table 49. Stevanato Group Major Business
   Table 50. Stevanato Group On-body Injectors Product and Services
   Table 51. Stevanato Group On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 52. Stevanato Group Recent Developments/Updates
   Table 53. Sonceboz Basic Information, Manufacturing Base and Competitors
   Table 54. Sonceboz Major Business
   Table 55. Sonceboz On-body Injectors Product and Services
   Table 56. Sonceboz On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 57. Sonceboz Recent Developments/Updates
   Table 58. Lohmann Therapie-Systeme Basic Information, Manufacturing Base and Competitors
   Table 59. Lohmann Therapie-Systeme Major Business
   Table 60. Lohmann Therapie-Systeme On-body Injectors Product and Services
   Table 61. Lohmann Therapie-Systeme On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 62. Lohmann Therapie-Systeme Recent Developments/Updates
   Table 63. Elcam Drug Delivery Devices (E3D) Basic Information, Manufacturing Base and Competitors
   Table 64. Elcam Drug Delivery Devices (E3D) Major Business
   Table 65. Elcam Drug Delivery Devices (E3D) On-body Injectors Product and Services
   Table 66. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
   Table 67. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
   Table 68. Global On-body Injectors Sales Quantity by Manufacturer (2018-2023) & (K Units)
   Table 69. Global On-body Injectors Revenue by Manufacturer (2018-2023) & (USD Million)
   Table 70. Global On-body Injectors Average Price by Manufacturer (2018-2023) & (US$/Unit)
   Table 71. Market Position of Manufacturers in On-body Injectors, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
   Table 72. Head Office and On-body Injectors Production Site of Key Manufacturer
   Table 73. On-body Injectors Market: Company Product Type Footprint
   Table 74. On-body Injectors Market: Company Product Application Footprint
   Table 75. On-body Injectors New Market Entrants and Barriers to Market Entry
   Table 76. On-body Injectors Mergers, Acquisition, Agreements, and Collaborations
   Table 77. Global On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
   Table 78. Global On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
   Table 79. Global On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
   Table 80. Global On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
   Table 81. Global On-body Injectors Average Price by Region (2018-2023) & (US$/Unit)
   Table 82. Global On-body Injectors Average Price by Region (2024-2029) & (US$/Unit)
   Table 83. Global On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 84. Global On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 85. Global On-body Injectors Consumption Value by Type (2018-2023) & (USD Million)
   Table 86. Global On-body Injectors Consumption Value by Type (2024-2029) & (USD Million)
   Table 87. Global On-body Injectors Average Price by Type (2018-2023) & (US$/Unit)
   Table 88. Global On-body Injectors Average Price by Type (2024-2029) & (US$/Unit)
   Table 89. Global On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 90. Global On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 91. Global On-body Injectors Consumption Value by Application (2018-2023) & (USD Million)
   Table 92. Global On-body Injectors Consumption Value by Application (2024-2029) & (USD Million)
   Table 93. Global On-body Injectors Average Price by Application (2018-2023) & (US$/Unit)
   Table 94. Global On-body Injectors Average Price by Application (2024-2029) & (US$/Unit)
   Table 95. North America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 96. North America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 97. North America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 98. North America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 99. North America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
   Table 100. North America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
   Table 101. North America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
   Table 102. North America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
   Table 103. Europe On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 104. Europe On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 105. Europe On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 106. Europe On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 107. Europe On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
   Table 108. Europe On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
   Table 109. Europe On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
   Table 110. Europe On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
   Table 111. Asia-Pacific On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 112. Asia-Pacific On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 113. Asia-Pacific On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 114. Asia-Pacific On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 115. Asia-Pacific On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
   Table 116. Asia-Pacific On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
   Table 117. Asia-Pacific On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
   Table 118. Asia-Pacific On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
   Table 119. South America On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 120. South America On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 121. South America On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 122. South America On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 123. South America On-body Injectors Sales Quantity by Country (2018-2023) & (K Units)
   Table 124. South America On-body Injectors Sales Quantity by Country (2024-2029) & (K Units)
   Table 125. South America On-body Injectors Consumption Value by Country (2018-2023) & (USD Million)
   Table 126. South America On-body Injectors Consumption Value by Country (2024-2029) & (USD Million)
   Table 127. Middle East & Africa On-body Injectors Sales Quantity by Type (2018-2023) & (K Units)
   Table 128. Middle East & Africa On-body Injectors Sales Quantity by Type (2024-2029) & (K Units)
   Table 129. Middle East & Africa On-body Injectors Sales Quantity by Application (2018-2023) & (K Units)
   Table 130. Middle East & Africa On-body Injectors Sales Quantity by Application (2024-2029) & (K Units)
   Table 131. Middle East & Africa On-body Injectors Sales Quantity by Region (2018-2023) & (K Units)
   Table 132. Middle East & Africa On-body Injectors Sales Quantity by Region (2024-2029) & (K Units)
   Table 133. Middle East & Africa On-body Injectors Consumption Value by Region (2018-2023) & (USD Million)
   Table 134. Middle East & Africa On-body Injectors Consumption Value by Region (2024-2029) & (USD Million)
   Table 135. On-body Injectors Raw Material
   Table 136. Key Manufacturers of On-body Injectors Raw Materials
   Table 137. On-body Injectors Typical Distributors
   Table 138. On-body Injectors Typical Customers

List of Figures

   Figure 1. On-body Injectors Picture
   Figure 2. Global On-body Injectors Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
   Figure 3. Global On-body Injectors Consumption Value Market Share by Type in 2022
   Figure 4. Electronic Injectors Examples
   Figure 5. Mechanical Injectors Examples
   Figure 6. Global On-body Injectors Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
   Figure 7. Global On-body Injectors Consumption Value Market Share by Application in 2022
   Figure 8. Immuno-oncology Examples
   Figure 9. Cardiovascular Diseases Examples
   Figure 10. Neurological Diseases Examples
   Figure 11. Others Examples
   Figure 12. Global On-body Injectors Consumption Value, (USD Million): 2018 & 2022 & 2029
   Figure 13. Global On-body Injectors Consumption Value and Forecast (2018-2029) & (USD Million)
   Figure 14. Global On-body Injectors Sales Quantity (2018-2029) & (K Units)
   Figure 15. Global On-body Injectors Average Price (2018-2029) & (US$/Unit)
   Figure 16. Global On-body Injectors Sales Quantity Market Share by Manufacturer in 2022
   Figure 17. Global On-body Injectors Consumption Value Market Share by Manufacturer in 2022
   Figure 18. Producer Shipments of On-body Injectors by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
   Figure 19. Top 3 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
   Figure 20. Top 6 On-body Injectors Manufacturer (Consumption Value) Market Share in 2022
   Figure 21. Global On-body Injectors Sales Quantity Market Share by Region (2018-2029)
   Figure 22. Global On-body Injectors Consumption Value Market Share by Region (2018-2029)
   Figure 23. North America On-body Injectors Consumption Value (2018-2029) & (USD Million)
   Figure 24. Europe On-body Injectors Consumption Value (2018-2029) & (USD Million)
   Figure 25. Asia-Pacific On-body Injectors Consumption Value (2018-2029) & (USD Million)
   Figure 26. South America On-body Injectors Consumption Value (2018-2029) & (USD Million)
   Figure 27. Middle East & Africa On-body Injectors Consumption Value (2018-2029) & (USD Million)
   Figure 28. Global On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 29. Global On-body Injectors Consumption Value Market Share by Type (2018-2029)
   Figure 30. Global On-body Injectors Average Price by Type (2018-2029) & (US$/Unit)
   Figure 31. Global On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 32. Global On-body Injectors Consumption Value Market Share by Application (2018-2029)
   Figure 33. Global On-body Injectors Average Price by Application (2018-2029) & (US$/Unit)
   Figure 34. North America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 35. North America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 36. North America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
   Figure 37. North America On-body Injectors Consumption Value Market Share by Country (2018-2029)
   Figure 38. United States On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 39. Canada On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 40. Mexico On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 41. Europe On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 42. Europe On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 43. Europe On-body Injectors Sales Quantity Market Share by Country (2018-2029)
   Figure 44. Europe On-body Injectors Consumption Value Market Share by Country (2018-2029)
   Figure 45. Germany On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 46. France On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 47. United Kingdom On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 48. Russia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 49. Italy On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 50. Asia-Pacific On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 51. Asia-Pacific On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 52. Asia-Pacific On-body Injectors Sales Quantity Market Share by Region (2018-2029)
   Figure 53. Asia-Pacific On-body Injectors Consumption Value Market Share by Region (2018-2029)
   Figure 54. China On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 55. Japan On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 56. Korea On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 57. India On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 58. Southeast Asia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 59. Australia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 60. South America On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 61. South America On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 62. South America On-body Injectors Sales Quantity Market Share by Country (2018-2029)
   Figure 63. South America On-body Injectors Consumption Value Market Share by Country (2018-2029)
   Figure 64. Brazil On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 65. Argentina On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 66. Middle East & Africa On-body Injectors Sales Quantity Market Share by Type (2018-2029)
   Figure 67. Middle East & Africa On-body Injectors Sales Quantity Market Share by Application (2018-2029)
   Figure 68. Middle East & Africa On-body Injectors Sales Quantity Market Share by Region (2018-2029)
   Figure 69. Middle East & Africa On-body Injectors Consumption Value Market Share by Region (2018-2029)
   Figure 70. Turkey On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 71. Egypt On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 72. Saudi Arabia On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 73. South Africa On-body Injectors Consumption Value and Growth Rate (2018-2029) & (USD Million)
   Figure 74. On-body Injectors Market Drivers
   Figure 75. On-body Injectors Market Restraints
   Figure 76. On-body Injectors Market Trends
   Figure 77. Porters Five Forces Analysis
   Figure 78. Manufacturing Cost Structure Analysis of On-body Injectors in 2022
   Figure 79. Manufacturing Process Analysis of On-body Injectors
   Figure 80. On-body Injectors Industrial Chain
   Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
   Figure 82. Direct Channel Pros & Cons
   Figure 83. Indirect Channel Pros & Cons
   Figure 84. Methodology
   Figure 85. Research Process and Data Source